# Tanta University

Organization · id `cardio:org-tanta-university` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 016jp5b92](<https://ror.org/016jp5b92>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 016jp5b92 by an exact name.

## The registry's words

- Sponsor name: Tanta University
- Sponsor class: OTHER
- ROR name: Tanta University

## Connected pages

- Sponsors: Type 2 Diabetic Patients Maintained on Statin Therapy (`cardio:ct-nct03784703`)
- Sponsors: Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level (`cardio:ct-nct03990480`)
- Sponsors: Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression (`cardio:ct-nct05373680`)

## Provenance

Content hash: f62d0cab431b88486c4d68e5843e660153f8331d36b6e834c96e172d712e558f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
